Thin drug pipelines prompted the biopharmaceuticals licensing splurge of 2006/7. Now pharma and large biotechs are looking to tap into university research too.
The exchange of knowledge requires professional people who understand how to do it – including how to manage IP, says Gilles Capart from ProTon Europe.
Tough news for America. China’s technological development is set to make it the main driver of world’s economy – and an integrated Europe could overtake it too.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.